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Background. Adipose tissue patterning has a major influence on the risk of developing chronic disease. Environmental
influences on both body fat patterning and appetite regulation are not fully understood. This study was performed to
investigate the impact of resistant starch (RS) on adipose tissue deposition and central regulation of appetite in mice.
Methodology and Principle Findings. Forty mice were randomised to a diet supplemented with either the high resistant
starch (HRS), or the readily digestible starch (LRS). Using
1H magnetic resonance (MR) methods, whole body adiposity,
intrahepatocellular lipids (IHCL) and intramyocellular lipids (IMCL) were measured. Manganese-enhanced MRI (MEMRI) was
used to investigate neuronal activity in hypothalamic regions involved in appetite control when fed ad libitum. At the end of
the interventional period, adipocytes were isolated from epididymal adipose tissue and fasting plasma collected for hormonal
and adipokine measurement. Mice on the HRS and LRS diet had similar body weights although total body adiposity,
subcutaneous and visceral fat, IHCL, plasma leptin, plasma adiponectin plasma insulin/glucose ratios was significantly greater
in the latter group. Adipocytes isolated from the LRS group were significantly larger and had lower insulin-stimulated glucose
uptake. MEMRI data obtained from the ventromedial and paraventricular hypothalamic nuclei suggests a satiating effect of the
HRS diet despite a lower energy intake. Conclusion and Significance. Dietary RS significantly impacts on adipose tissue
patterning, adipocyte morphology and metabolism, glucose and insulin metabolism, as well as affecting appetite regulation,
supported by changes in neuronal activity in hypothalamic appetite regulation centres which are suggestive of satiation.
Citation: So P-W, Yu W-S, Kuo Y-T, Wasserfall C, Goldstone AP, et al (2007) Impact of Resistant Starch on Body Fat Patterning and Central Appetite
Regulation. PLoS ONE 2(12): e1309. doi:10.1371/journal.pone.0001309
INTRODUCTION
The link between obesity, adipose distribution, premature
mortality and morbidity is one of the most enduring observations
in the field of nutrition [1]. The rise in obesity and associated risks
have become a major public health issue globally [2]. Although
weight gain is ultimately the result of an overall positive energy
balance, the environmental and genetic interplay that accounts for
the dramatic rise in obesity is not fully understood. Nutritionally,
there have been many significant changes in the profile of
energetic nutrients over the last 100 years [3]. By far the largest
research focus has been towards the impact of dietary fat on body
composition. This has ignored not only the decrease in total
carbohydrate intake but a change in the quality of carbohydrate
that we have consumed over the last century. Recently, interest
has been stimulated in understanding the relationship between
dietary carbohydrate, appetite regulation, body weight and body
composition [4,5]. There is epidemiological evidence supporting
changes in carbohydrate consumption have contributed to an
increase in obesity [6]. Also, there have been reports of body
composition being affected by carbohydrate type in small animals
[7]. It would appear that slowly absorbed fermentable carbohy-
drate results in lower body fat content with no change in overall
body weight [8]. At the present time, the mechanism for these
observations is unclear. There is also some provisional evidence
that diets high in resistance starch (RS) may have an effect on
adipocyte metabolism by affecting the release of adiponectin [9].
The metabolic impact of RS in humans has recently been
demonstrated by Robertson etal [10]. In this study supplementa-
tion with RS lead to a increase insulin sensitivity and a reduction
in glycerol and free fatty acids across subcutaneous adipose tissue
[10]. This is suggestive of a change in adipocyte metabolism that
may lead to a change in insulin sensitivity. Also, fermentable
carbohydrate such as RS and inulin has been demonstrated to
increase the release of gut hormones with roles in appetite
regulation and possibly, leptin release [9,11].
Some of the effects of high intakes of RS and fermentable
carbohydrate described above such as changes in body compo-
sition are suggestive of a central role in energy homeostasis. This
has been technically difficult to evaluate. In this study, we use
magnetic resonance imaging (MRI) and magnetic resonance
spectroscopy (MRS) to determine body composition, not only in
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PLoS ONE | www.plosone.org 1 December 2007 | Issue 12 | e1309levels of traditional adipose fat but also ectopic fat levels such as
intrahepatocyte and intramyocyte fat [12]. We also used a newly
developed functional imaging method, manganese-enhanced MRI
(MEMRI), to assess the impact of dietary starches on appetite
centres in the hypothalamus [13,14,15]. This novel method allows
in vivo assessment of brain activity, making it ideal for longitudinal
dietary studies. Moreover, we have shown that neuronal activity is
unaffected by the presence of Mn
2+ ions in our protocol and that
this technique produces similar results to traditional c-Fos
expression based methods to detect neuronal activation [14].
We hypothesised that mice fed a diet high in RS as a model of
fermentabledietaryfibre wouldhavesimilar bodyweightscompared
to those with a low RS intake but have differences in body
composition, metabolic profile and central appetite regulation.
RESULTS
Body Weight, Food Intake and Body Composition
Data
Both groups of mice maintained for 8 weeks on the LRS and HRS
diets had similar body weights throughout the time-course (Fig. 1).
This was despite a significantly higherfood intakeby the HRS group
(Fig. 2a), reflecting animal adaptation to the energy dilution effect of
the RS enriched feed. However, the increase in total weight of food
consumed by individual mice in the HRS group did not fully
compensate for the more energy dilute feed, this includes estimation
of the energy recovery from the high resistant starch feed through
fermentation. In the high HRS the total energy intake remains
significantly lower in the HRS mice (Fig 2b). Assessment of total
percentage adiposity by whole body
1H MRS, indicated that despite
similar weight gains between the two groups, the weight gained by
the LRS group arise from deposition of adipose fat rather than lean
tissue mass (Fig. 3). By segmentation analysis of whole body MRI
data, visceral and subcutaneous adipose tissue deposits were
determined (Fig. 4) to be higher in the LRS group (P,0.05).
Visceral adipose tissue deposits were 2.4560.27 g and 1.6460.19 g
for LRS and HRS groups (P,0.05), respectively, and subcutaneous
adipose tissue, 3.7460.37 g and 2.6760.32 g for the LRS and HRS
groups (P,0.05), respectively.
Greater deposition of lipids in hepatocytes were detected in the
LRS group, relative intrahepatocellular lipid (IHCL) levels were
12.461.7 and 4.360.6 for the LRS and HRS groups, respectively
(P,0.01). No difference in the levels of relative intramyocellular
lipid (IMCL) were detected between the two dietary groups.
Figure 1. The effect of HRS and LRS diets on average body weights
over the 8-week dietary interventional period. No significant
difference was observed in the body weight between the two groups
of animals [two way ANOVA with post-testing by Bonferonni correction,
n=16 and 20 for HRS and LRS groups, respectively.)
doi:10.1371/journal.pone.0001309.g001
Figure2.TheeffectofHRSandLRSonaverageweeklyfoodandenergy
intake per mouse over the 8 week dietary intervention period.
Figure 2a: The effect of HRS and LRS on average weekly food intake per
mouseoverthe8 weekdietaryinterventionalperiod.Figure2b:Theeffect
of HRS and LRS on average weekly energy intake (KJ/mouse/week) over
the 8 week dietary intervention period. [***, significance at level P,0.001,
twowayANOVAwithpost-testingbyBonferonnicorrection,n=16and20
for HRS and LRS groups, respectively.]
doi:10.1371/journal.pone.0001309.g002
Figure 3. The effect of HRS and LRS diets on percentage adiposity
over the 8 week dietary interventional period. [***, significance at
level P,0.001, two way ANOVA with post-testing by Bonferonni
correction, n=16 and 20 for HRS and LRS groups, respectively.]
doi:10.1371/journal.pone.0001309.g003
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Changes in signal intensity due to Mn
2+ uptake was measured in
selected regions of interest (ROI) on the MRI image (Figure 5).
Figure 5 shows the time course for Mn
2+ uptake as a percentage of
baseline following IV infusion of Mn
2+ in the arcuate hypotha-
lamic nucleus (ARC), ventromedial hypothalamic nucleus (VMH)
and paraventricular hypothalamic nucleus (PVN). The 4
th
ventricle is located outside the blood-brain-barrier (BBB) and
signal enhancement in this area allows for normalisation of the
enhancement curves for Mn
2+ arrival time into the brain. No
significant difference was observed in MEMRI of the 4
th ventricle
between the LRS and HRS groups, suggesting Mn
2+ uptake into
this area outside the BBB to be the same in both groups. Although
MEMRI in the ARC is greater in the HRS group compared to the
LRS group, statistical difference was not reached (P,0.2).
However, both the VMH and the PVN show significantly greater
uptake in the LRS compared to the HRS group (P,0.05),
indicating greater activation in the former dietary group.
Adipocyte Data
Adipocytes isolated from the epididymal fat of LRS mice were
found to be of a significantly larger size (7.8960.12 mm) than those
from the HRS mice (6.9160.09 mm, P,0.001). A higher
borderline insulin-stimulated glucose uptake was observed in the
isolated adipocytes from the HRS group (273.0650.7 % above
baseline adipose tissue) compared to those from the LRS group
(159.8622.8 % above baseline adipose tissue, P,0.05).
Plasma Analysis
Table 1 shows that plasma leptin and adiponectin were
significantly higher in the LRS group compared to the HRS,
despite no overall change in body weight. The glucose:insulin
ratio, in the face of normal glycaemia was significantly higher in
the HRS group suggesting ingestion of higher amounts of RS led
to a more insulin-sensitive animal.
DISCUSSION
Maintenance for 8 weeks on either the LRS or HRS diets lead to
similar weight gain but differences in whole body adiposity. This is
despite the HRS group consuming significantly more total weight
of food in response to the greater energy dilution in the HRS feed.
However despite this increase in total weight of food the energy
intake in the animals on the HRS diet was significantly lower than
the LRS group. For the animals in both groups to have the same
total body weight would suggest the HRS animal had reduced
energy expenditure, although this was not directly measured in this
study. It is known that when animals are pair fed RS enriched
feeds [7] there is no change in total body weight but similar
changes in body composition as reported in this paper. However,
it is difficult to unpick if some of the observations made in the
study are due to a reduced energy intake and the metabolic
compensation the animal uses to keep its body weight the same as
the LRS group, but the vector for the changes is the HRS diet.
These observations make the functionalMRI finding, discussed
below, even more surprising.
Significant differences in total, subcutaneous and visceral
adipose tissue was observed, the ingestion of a low RS diet
leading to significantly greater deposition of adipose tissue. These
observations are similar to those of Pawlak et al [7] in which rats
maintained on a diet low in RS had significantly greater body fat
and less lean body mass than those given a high RS diet, despite
having similar mean body weights. We have not only confirmed
the findings of others [7] but have added to such observations with
the demonstration that the IHCL level is significantly higher in the
animals fed a LRS diet. This may be a critically important
observation given the mounting evidence to the central role of liver
triacylglycerol in the pathogenesis of insulin resistance, a
mechanism which is not really fully understood [16,17]. It is
interesting that in this study there is a increase in the
insulin:glucose ratio in the LRS group, suggesting an increase in
insulin resistance, a similar observation was made by Pawlak et al,
in which a more comprehensive assessment of insulin and glucose
metabolism was made [7]. This would suggest the change in body
composition inducted by the HRS diet (lower percentage total
body fat, arising from both lower levels of visceral and
subcutaneous fat, and IHCL) has a positive impact on insulin
and glucose handling.
We also observed changes in adipocyte morphology arising
from differences in the diet, adipocytes were significantly larger in
the LRS fed animals. There is a well established relationship
between adipocyte size and insulin sensitivity, i.e., the larger the
adipocytes, the lower their sensitivity to insulin [18]. This has been
Figure 4. Typical transverse abdominal MRI and associated segmented images of mice on HRS and LRS diets.
doi:10.1371/journal.pone.0001309.g004
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This is consistent with the significantly lower insulin-stimulated
glucose uptake rate observed in the adipocytes isolated from
animals fed the LRS diet. Our team and others have demonstrated
that a reduction in insulin-stimulated glucose uptake directly
relates to a reduction in whole body insulin sensitivity [21,22,23].
The lower insulin-stimulated glucose uptake together with the
significantly higher insulin:glucose ratio in the LRS group suggests
these animals are moving towards a more insulin resistant state.
Potential mechanisms for the changes in adipocyte size and insulin
sensitivity are unclear. It is possible a link exists between short
chain fatty acid production from the fermentation of RS and the
change in adipocyte morphology. Recently, it has been reported
that the G protein receptor, GPCR43, on adipocytes may play a
role in adipocyte differentiation and proliferation [24]. The ligands
for these receptors appear to be the short chain fatty acids, acetate
and propionate, which although not measured in this study, has
been well documented to be produced from fermentation of RS
[25]. Further, there is recent evidence that activation of GPCR43
by acetate and propionate causes a decrease in leptin secretion and
an increase in adipocyte differentiation [26]. The observations
made in our study are similar to that by Slama et al who reported
significantly larger adipocyte size and lower insulin-stimulated
glucose oxidation in rats fed with diets of low fermentable content
[27]. The same group also reported an increase in fatty acid
storage enzymes and lipogenesis in such animals [28]. Taken
together the results support the hypothesis that RS and possibly its
fermentation in the large bowel may influence adipocyte
metabolism.
An interesting observation is the significant difference in plasma
leptin concentrations, with the LRS group having significantly
higher levels despite similar body weights. This appears to support
Figure 5. Representative baseline (pre-contrast) MRI images of the mouse brain showing assignment of regions of interest (ROIs) in various
brain areas from which signal intensities (SI) were obtained. Time course of changes in SI (as a percentage of baseline) before and at various times
after IV manganese chloride infusion in the (A) ARC, (B) VMH and the (C) PVN. Data are presented as means of three consecutive image
acquisitions6SEM. Significant differences were observed in the VMH, and PVN brain areas (P,0.05) but not in the ARC. Key: ARC, arcuate
hypothalamic nucleus; VMH, ventromedial hypothalamic nucleus; PVN, paraventricular hypothalamic nucleus; LRS, low resistant starch diet; HRS, high
resistant starch diet.
doi:10.1371/journal.pone.0001309.g005
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and size of the adipocyte rather than the overall body weight with
the LRS group having significantly larger adipocytes [29]. Levels
of adiponectin were also significantly higher in the LRS animals,
appearing to be at odds with the findings of elevated leptin levels,
larger adipocytes and generally higher insulin:glucose ratio
observed in these animals. Leptin and adiponectin is known to
be inversely regulated in vivo [30], however, this relationship is not
observed in vitro [31], suggesting that the inverse relationship
observed in vivo is mediated to some extent by indirect
mechanisms. Huypens [32] hypothesize the inverse relationship
between leptin and adiponecti may operate via a hypothalamic
mechanism. Evidence for neural regulation include that stimula-
tion of the adrenal-sympathetic axis by leptin results in potent
inhibition of adiponectin production and systemic insulin
sensitivity [33]. Increased central leptin availability rapidly induces
SOCS-3 expression in adipose tissue [34] and markedly lowers
circulating adiponectin levels in normal and ob/ob mice [35].
Further, hypertensive patients exhibiting chronic inhibition of the
sympathetic drive have increased circulating adiponectin [36]. In
our study, the paradoxical increase in adiponectin levels
concomitant with increased leptin levels observed in the LRS
mice is consistent with induction of leptin resistance in these mice.
This is comparable to the selective hypothalamic leptin resistance
observed in mice following gold thioglucose treatment [37]. In
such animals, increased adiponectin production was detected
during the early phase of the obesity syndrome induced by gold
thioglucose [32].
Our team has recently demonstrated the utility of MEMRI in
understanding changes in appetite regulation in the hypothalamus,
showing the sensitivity of this technique to detect predicable
changes between fasted and ad libitum fed animals in the
hypothalamus [15], and changes following hormonal stimulus
[14]. We have recently published validation of this techniques
against other gold standard methodologies [13]. In our previous
studies, increased Mn
2+ uptake, i.e., overall increased neuronal
activation, was observed in the ARC, PVN and VMN brain areas
in fasted animals compared to ad libitum fasted animals [14].
Administration of oxyntomodulin to fasted animals, led to a
reduction in Mn
2+ uptake in the VMH and PVN areas, resulting
in a pattern of Mn
2+ uptake similar to that observed in ad libitum
fed animals [14]. In our current study, Mn
2+ uptake in the VMH
and PVN was significantly lower in the HRS animal compared to
the LRS animal, reflecting an animal in a more satiated state.
MEMRI was also generally lower in the ARC, although not
significantly. Thus, using MEMRI we were able to gain an insight
into the impact of low and high RS diets on neuronal activation in
hypothalamic areas with roles in appetite regulation. These data
are even more surprising considering the lower energy intake in
the HRS group. The data suggests that there may be appetite
regulatory differences between animals exposed to varying
amounts of RS with the LRS animals producing MEMRI data
closer to fasted animals and the HRS animals to that of sated
animals. This is despite the lower energy intake in the HRS diet. It
is possible with the demonstrated effect on central appetite
regulation, that there may be effects on animal behaviour, which
we did not measure in this experiment, such as a decrease in
movement that would account of the similar body weight. Initially,
we had expected the MEMRI pattern of the HRS group to be
comparable to the fasted state since these animals exhibited a
greater food intake and lower energy intake, i.e., appear to have
increased appetite. However, food intake is regulated by nutrient
sensing hypothalamic neurones with glucoprivic conditions eliciting
low ATP concentrations in neuropeptide Y/agouti-related protein
(AgRP) neurones resulting in induction of AgRP expression and so,
increased food intake [38]. Due to the low glycemic nature of a diet
inwhichthecarbohydratecomponentisfulfilledbyRS,postprandial
glucose levels would be relatively lower in animals on the HRS diet
compared to those on the LRS diet, explaining the overall increased
food intakeobservedinthe formeranimals:theincreased foodintake
compensating for the low calorific value of the HRS diet. However,
once ATP concentrations in AgRP neurones have been restored,
AgRP expression is inhibited, leading to a cessation of feeding. The
similarity of the MEMRI pattern between the HRS group and
animals in the ad libitum fed state suggests that ingestion of significant
amounts of RS leads to an animal predominantly in a satiated state.
It is likely the observed effects of the RS starch diet on body
composition and appetite regulation are multifactorial. For
example, increasing RS reduces energy density of the diet. The
influence of energy density of the diet on food intake and adiposity
has been already demonstrated in other studies both in animal and
human [39]. Increasing RS modifies gastric and intestinal motility
and increase distal metabolism. These effects could modify the
release of gut hormones involved in the control of food intake [8].
Theincreaseddistalgutmetabolismleadstoanincreasedproduction
of short chain fatty acids. It is possible that short chain fatty acids
have a role in adipose tissue remodelling and hepatic metabolism
[40]. Increasing resistant starch also reduces glycemix index which is
known to modify insulin/glucose response a possible mechanism for
appetite reduction as discussed above [4].
In summary, we have demonstrated that a diet rich in RS has a
significant impact on adipose tissue patterning and IHCL
deposition. We provide evidence that RS has a significant impact
on glucose and insulin metabolism, mediated by major changes in
adipocyte morphology and metabolism. MEMRI data suggest that
RS can significantly influence hypothalamus areas with a major
role in appetite regulation. The MEMRI patterning in the HRS
group are similar to those of a satiated animal. This is despite the
higher plasma leptin in the lower RS group. This study highlights
the need for integrated physiological inquiry to understand the
mechanisms behind nutrient induced physiological change. If
these observations are reflected in humans, then there is the
potential for major health benefits of including RS as the major
carbohydrate in the diet, which may support provisional
epidemiological evidence of reduced diet related disease in
population who consume high levels of RS.
Table 1. The effect of resistant starch on plasma levels of
insulin, glucose and selected adipokines.
......................................................................
Variable High Resistant Starch Low Resitant Starch p
Mean SEM Mean SEM
IL-6 (pmol/l) 1030.99 164.30 993.57 94.12 ns
Insulin (pmol/l) 75.25 44.33 106.23 48.89 ns
Glucose (mmol/l) 17.40 4.80 16.89 5.79 ns
I:G ratio 4.33 1.66 6.29 2.78 0.04
Leptin (pmol/l) 262.86 248.34 742.16 480.23 0.01
MCP-1 (pmol/l) 113.53 43.12 143.83 77.05 ns
Resistin (pmol/l) 81.74 31.05 103.56 55.48 ns
tPAI-1 (pmol/l) 26.87 15.72 41.63 15.95 0.06
Adiponectin (ug/ml) 14.83 4.97 22.51 9.25 0.01
IL-6=Interleukin-6, MCP-1=monocyte chemotactic protein-1, tPAI-
1=plasminogen activator inhibitor 1. Adiponectin is measured in ug/ml due to
the different protein population.
doi:10.1371/journal.pone.0001309.t001
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Mice were given diets supplemented with either the RS starch, Hi-
Maize
TM (National Starch and Chemical Company, Lancashire,
UK.)whichis60%RS,orthe readilydigestiblestarch,AMIOCA
TM
(National Starch and Chemical Company, Lancashire, UK.) which
contains no RS. We used RSas a model of fermentable dietary fibre.
Whole body adiposity, intrahepatocellular lipid (IHCL) and
intramyocellular lipid (IMCL) content were measured using
1H
MRI and MRS methods. MEMRI was also used to measure
hypothalamic neuronal activity in the ad libitum fed state at the end
of the study period. Body weights and food intake, over the 8 week
period of dietary intervention were also recorded. At the end of the
interventional period, adipocytes were isolated from epididymal
adipose tissue to determine insulin sensitivity and adipocyte size
Animals and Treatment
All animal studies were performed in accordance with the UK
Animals Scientific Procedures Act (1986). Animals were allowed
ad libitum access to drinking water and chow. Animals where
randomly assigned to either the high or low RS diet (Harlan,
Bichester., Oxfordshire, UK) table 2. Animals were housed in
groups 4 per cage under conditions of controlled temperature (21–
23uC) and light (12-h light, 12 h dark cycle; lights on at 07:00 h).
Forty male mice (C57BL/6, 3 weeks old, Harlan UK) were
obtained and whole body
1H MRS performed (as described below)
following a 16 h fast. Based on whole body adiposity measure-
ments by MRS and body weight data, mice were allocated into
groups of four and housed in individually ventilated cages.
Mice were then maintained for 8 weeks on either a low RS diet
(LRS, 6 cages of 4 animals) or a high RS diet (HRS, 4 cages of 4
animals). The compositions of the LRS and HRS diets were
nutritionally similar ( 69% carbohydrate, 20% protein and 11% fat
) except the former contained AMIOCA
TM starch (53% available
carbohydrate of feed by weight) as the carbohydrate component
whilst the latter contained Hi-Maize
TM starch (32% non digestible
carbohydrate and 21% available carbohydrate of feed by weight).
In calculating the energy content of the feed allowance was made
for fermentation and recovery of energy from the RS. This had an
impact on the energy density of the feed with AMIOCA
TM
providing 15kJ/g and Hi-Maize
TM providing 10.5 kJ/g (Table 1).
This diet was similar to that used by Pawlak et al [7]
Whole body MRI was also performed at weeks 4 and 8 post-
dietary intervention as well as in vivo localised
1H MRS of the liver
and muscle at the latter time-point for selected weight-matched
animals (n=8 and 11 for HRS and LRS, respectively). Weekly
body weights and food intakes were also recorded throughout the
dietary interventional period.
At the end of the interventional period, fasting blood was
obtained by cardiac puncture from the animals which had been
assessed by whole body MRI and localized
1H MRS. Blood was
collected into lithium heparin tubes prior to centrifugation for
separation of plasma. A sample of epididymal fat (white adipose
tissue) was retained for adipocyte isolation (as described below).
Magnetic Resonance Studies
Measurement of Whole Body Adiposity and Individual
Adipose Tissue Deposits Anaesthesia was induced and
maintained by inhalation of 1–2% isoflurane/oxygen mix.
Following a 16 h fast, whole body
1H MRS spectra, to assess
whole body adiposity, were obtained on a Varian Inova 4.7T
system (Varian Inc., CA, USA) with the following parameters:
repetition time (TR) 20 s, 45u pulse and 4 averages. The total
percentage adiposity was calculated as previously described [41].
Whole body MRI was also performed at the end of the 8-week
dietary interventional period to determine the amounts of internal
and subcutaneous fat. A standard spin-echo MRI sequence was
employed with TR 2200 ms, echo time (TE) 20 ms, matrix size
2566192, field of view (FOV) 45645 cm, 2 averages and 50
contiguous slices of 2 mm thickness. Segmentation analysis
(SliceOmatic
TM, TomovisionH, Canada) was performed blindly
by the observer on whole body MRI data sets from selected
weight-matched animals (n=8 per dietary group) to determine
levels of visceral and subcutaneous adipose tissue.
Measurement of Intra-Hepatocellular (IHCL) and Intra–
Myocellular (IMCL) Lipid Levels Localised
1H MRS of the
liver and muscle was performed at the end of the 8-week
interventional period to assess intracellular lipid levels. Placement
of a 36363 mm voxel in the organs was guided by pilot MRI
Table 2. Metabolisable energy content of Mice feed
..................................................................................................................................................
Ingredient High Resistant Starch Low Resistant Starch
g/kg kJ/g kJ/kg g/kg kJ/g kJ
Casein 200 15 2985 200 15 2985
DL-Methionine 3 17 50 3 17 50
Maltodextrin 120 16 1906 120 16 1906
HI-MAIZE 260 (Resistant Starch)* 530 7 3545 0 0 0
AMIOCA TF (Waxy Maize Starch) 0 0 0 530 15 8042
Soybean Oil 50 38 1881 50 38 1881
Cellulose 45 0 0 45 0 0
Mineral Mix 35 3 102 35 3 102
Calcium Phosphate 5 0 0 5 0 0
Vitamin Mix 10 7 71 10 7 71
Choline Bitartrate 3 0 0 3 0 0
T B H Q 000 000
Energy density (kJ/gram) 10 15
Energy content estimated from fermentation salvage of resistant starch
doi:10.1371/journal.pone.0001309.t002
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9 ms and 64 averages, localised
1H MRS from the voxels were
collected. Relative IHCL and IMCL levels were calculated as
previously described [42].
Hypothalmic Neuronal Manganese-Enhanced MRI
MEMRI scans were performed on ad libitum 4 animals (weight
matched) from each dietary group as previously described on a
Varian Inova 9.4T scanner (16). Briefly, spin-echo multi-slice T1-
weighted imaging was performed with the following scanning
parameters: TR 600 ms; TE 10 ms, matrix size=2566192, FOV
25 mm625 mm and 1 transient, before and at various times after
intravenous (IV) infusion of manganese chloride (62.3 mM, 5 ml/g
MnCl2.4H2O, Sigma-Aldrich, Poole, U. K.). Each scan yielded
ten contiguous transverse slices of 1 mm thickness with ,100 mm
resolution, taking a total scan time of 1 min 57 s. The slice offset
for each mouse was aligned to identifiable anatomical features (the
4th ventricle and the anterior pituitary gland) with reference to a
standard mouse brain atlas [43] to ensure brains were in register
for all mice.
Primary Adipocyte Studies
The isolation of adipocytes from epididymal adipose tissue has
been described in detail elsewhere [44] and will only be detailed
briefly here. The samples were collected into Dulbecco’s Modified
Eagle Medium (DMEM, Sigma-Aldrich) containing 5% bovine
serum albumin (BSA, Sigma-Aldrich). The epididymal adipose
tissue samples were finely minced and DMEM, supplemented with
5% BSA and collagenase (Sigma-Aldrich) were added. The tissue
suspensions were placed in a vibrating water bath at 40 cycles/
minute (45 mins, 37uC). After incubation, cell suspensions were
then filtered through a 400 nm mesh and washed 3 times in a
glucose-free Krebs-Ringer phosphate (KRP) buffer with 5% BSA
(each wash involving 5 inversions). At no time were the adipocytes
left to stand for more than 5 mins without being agitated. In vitro
studies (see below) were then performed on approximately 30,000
isolated adipocytes. Cells were kept suspended throughout in a
vibrating water bath.
Measurement of Adipocyte Size Following adipocyte
isolation, an aliquot of the cell suspension was observed by
optical microscopy with a graticle placed over one objective lens.
The cells were manually counted in a 1:100 dilution of the cell
concentrate by means of a haemocytometer (with a 200 mm gap)
and the size measured using the graticle scale.
Measurement of Adipocyte Insulin-stimulated Glucose
Uptake This has been described in detail elsewhere [21,44].
The adipocytes were initially incubated (45 minutes, 37uC) in
500 mL of KRP with 5% BSA in the presence of 1 nM insulin
(Sigma-Aldrich) before the addition of 300 nM of a non-
metabolizable radiolabeled glucose analogue (0.1 mCi C-14 2-
deoxy-D-glucose). They were then incubated for a further
15 minutes before centrifugation through 500 mL of silicone oil.
Glucose uptake was calculated following liquid scintillation
counting of the radiolabeled glucose analogue tracer in the
isolated adipocytes.
Measurement of Plasma Parameters
Plasma from fasted mice was taken for measurement of hormones
and selected adipokines using fluorescent bead based assays
according to manufacturer’s instructions. Leptin, resistin, insulin,
total plasminogen activator inhibitor-1 (tPAI-1), interleukin-6 (IL-
6), and monocyte chemotactic protein-1 (MCP-1) were measured
using a multiplex kit and adiponectin, a single plex kit (Linco
Research, St. Charles, MO, USA) on a Luminex system (Austin,
Texas, USA). Plasma glucose was measured using a One Touch
Ultra meter and test strips (Milpitas, CA, USA).
Statistical Analysis
Values are quoted as mean6standard error of mean (SEM).
Significant differences between measured parameters from the
HRS and LRS groups were tested using either the Student’s t-test
or Mann-Whitney test, except for measurements of percentage
adiposity, food intake and body weight which was tested for
significance using the two way ANOVA with Bonferonni post-
testing. MEMRI data obtained from the two dietary groups was
tested for significance by repeated measures ANOVA. Significance
was taken as P,0.05
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